on concurrent thoracic radiotherapy and a cisplatin/etoposide regimen than on a paclitaxel/carboplatin regimen,
according to a new study. (Source: Modern Medicine)
phlebotomy technician classes phlebotomy training tucson phlebotomy tech schools
Thursday, 12 April 2012
Paclitaxel and carboplatin no help in lung cancer
NEW YORK (Reuters Health) - Patients with unresectable stage III non-small cell lung cancer do better
on concurrent thoracic radiotherapy and a cisplatin/etoposide regimen than on a paclitaxel/carboplatin regimen,
according to a new study. (Source: Modern Medicine)
on concurrent thoracic radiotherapy and a cisplatin/etoposide regimen than on a paclitaxel/carboplatin regimen,
according to a new study. (Source: Modern Medicine)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment